CathConnect

Executive Summary

CathConnect is a Minneapolis-based medical device company developing a novel safety device designed to prevent traumatic, accidental removals of indwelling urinary catheters. Founded in 2015 as a university capstone project, the company has transitioned into a venture-backed startup recognized for its innovative approach to a common and costly hospital complication. Accidental catheter removal affects millions of patients annually, leading to injuries, infections, extended hospital stays, and increased healthcare costs. CathConnect's device aims to mitigate these risks by securing the catheter and alerting caregivers when dislodgement is imminent, thereby improving patient safety and reducing clinical burden. The company is currently in the development stage, with a focus on regulatory clearance and initial commercialization. Given the large addressable market and strong clinical need, CathConnect represents a promising opportunity in the cardiac and medical device space, though it faces typical early-stage risks including regulatory hurdles and market adoption.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance or De Novo Classification70% success
• Q3 2026Series A or Series B Funding Round60% success
• Q2 2026Initial Clinical Data from Pilot Study75% success